These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25418950)

  • 41. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
    Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
    Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A thermal-cycling method for disaggregating monoclonal antibody oligomers.
    Sadavarte RH; Ghosh R
    J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
    Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months.
    Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.
    Kalonia C; Kumru OS; Kim JH; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Dec; 102(12):4256-67. PubMed ID: 24122556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of thermal and mechanical stress on the physical stability of human growth hormone and epidermal growth factor.
    Lim JY; Kim NA; Lim DG; Kim KH; Jeong SH
    Arch Pharm Res; 2015 Aug; 38(8):1488-98. PubMed ID: 25430693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of CZ-resin vials for packaging protein-based parenteral formulations.
    Qadry SS; Roshdy TH; Char H; Del Terzo S; Tarantino R; Moschera J
    Int J Pharm; 2003 Feb; 252(1-2):207-12. PubMed ID: 12550796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of Protein Aggregation in High Concentration Protein Solutions Utilizing Protein-Protein Interactions Determined by Low Volume Static Light Scattering.
    Hofmann M; Winzer M; Weber C; Gieseler H
    J Pharm Sci; 2016 Jun; 105(6):1819-1828. PubMed ID: 27157445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigating factors leading to fogging of glass vials in lyophilized drug products.
    Abdul-Fattah AM; Oeschger R; Roehl H; Bauer Dauphin I; Worgull M; Kallmeyer G; Mahler HC
    Eur J Pharm Biopharm; 2013 Oct; 85(2):314-26. PubMed ID: 23791681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Glass Delamination Risk in Pharmaceutical 10 mL/10R Vials.
    Ditter D; Nieto A; Mahler HC; Roehl H; Wahl M; Huwyler J; Allmendinger A
    J Pharm Sci; 2018 Feb; 107(2):624-637. PubMed ID: 28989023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity.
    Gabrielson JP; Brader ML; Pekar AH; Mathis KB; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2007 Feb; 96(2):268-79. PubMed ID: 17080424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agitation-induced aggregation and subvisible particulate formation in model proteins.
    Jayaraman M; Buck PM; Ignatius AA; King KR; Wang W
    Eur J Pharm Biopharm; 2014 Jul; 87(2):299-309. PubMed ID: 24462794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
    Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
    J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors Governing the Accuracy of Subvisible Particle Counting Methods.
    Ríos Quiroz A; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    J Pharm Sci; 2016 Jul; 105(7):2042-52. PubMed ID: 27287519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case study of nondelamination glass dissolution resulting in visible particles: implications for neutral pH formulations.
    Ratnaswamy G; Hair A; Li G; Thirumangalathu R; Nashed-Samuel Y; Brych L; Dharmavaram V; Wen ZQ; Fujimori K; Jing W; Sethuraman A; Swift R; Ricci MS; Piedmonte DM
    J Pharm Sci; 2014 Apr; 103(4):1104-14. PubMed ID: 24496956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between aggregation of therapeutic proteins and agitation parameters: Acceleration and frequency.
    Kizuki S; Wang Z; Torisu T; Yamauchi S; Uchiyama S
    J Pharm Sci; 2023 Feb; 112(2):492-505. PubMed ID: 36167196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations.
    Wu H; Randolph TW
    J Pharm Sci; 2019 Mar; 108(3):1110-1116. PubMed ID: 30773198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.
    Telikepalli S; Shinogle HE; Thapa PS; Kim JH; Deshpande M; Jawa V; Middaugh CR; Narhi LO; Joubert MK; Volkin DB
    J Pharm Sci; 2015 May; 104(5):1575-91. PubMed ID: 25753756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.